APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs of UDCA and t-UDCA

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drugs of UDCA and t-UDCA Industry Growth and Trends Forecast to 2032

2 January 2026104 pages

Choose your research edition.

Industry ResearchDrugs of UDCA and t-UDCA Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs of UDCA and t-UDCA Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Drugs of UDCA and t-UDCA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs of UDCA and t-UDCA Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs of UDCA and t-UDCA Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drugs of UDCA and t-UDCA market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drugs of UDCA and t-UDCA is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drugs of UDCA and t-UDCA is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs of UDCA and t-UDCA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs of UDCA and t-UDCA include Bruschettini, Daewoong Pharmaceutical, Dr. Falk Pharma, Epic Pharma, Grindeks, Impax, Lannett, Mitsubishi Tanabe Pharma and Viatris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drugs of UDCA and t-UDCA market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs of UDCA and t-UDCA market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs of UDCA and t-UDCA market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs of UDCA and t-UDCA.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Drugs of UDCA and t-UDCA market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs of UDCA and t-UDCA Market by Company

Bruschettini

Daewoong Pharmaceutical

Dr. Falk Pharma

Epic Pharma

Grindeks

Impax

Lannett

Mitsubishi Tanabe Pharma

Viatris

Shanghai Pharma

Teva

Drugs of UDCA and t-UDCA Segment by Type

t-UDCA

UDCA

Drugs of UDCA and t-UDCA Segment by Application

Hepatopathy

Gallstone

Biliary Disease

Other

Drugs of UDCA and t-UDCA Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs of UDCA and t-UDCA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs of UDCA and t-UDCA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs of UDCA and t-UDCA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs of UDCA and t-UDCA manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Drugs of UDCA and t-UDCA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of t-UDCA Table 2. Major Company of UDCA Table 3. Global Drugs of UDCA and t-UDCA Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 5. Global Drugs of UDCA and t-UDCA Sales Market Share in Volume by Type (2021-2026) Table 6. Global Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (US$ Million) Table 7. Global Drugs of UDCA and t-UDCA Sales Market Share in Value by Type (2021-2026) Table 8. Global Drugs of UDCA and t-UDCA Price by Type (2021-2026) & (US$/Unit) Table 9. Global Drugs of UDCA and t-UDCA Sales by Type (2027-2032) & (K Units) Table 10. Global Drugs of UDCA and t-UDCA Sales Market Share in Volume by Type (2027-2032) Table 11. Global Drugs of UDCA and t-UDCA Sales by Type (2027-2032) & (US$ Million) Table 12. Global Drugs of UDCA and t-UDCA Sales Market Share in Value by Type (2027-2032) Table 13. Global Drugs of UDCA and t-UDCA Price by Type (2027-2032) & (US$/Unit) Table 14. North America Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 15. North America Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 17. Europe Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 21. Latin America Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Type (2021-2026) & (US$ Million) Table 24. Drugs of UDCA and t-UDCA Industry Trends Table 25. Drugs of UDCA and t-UDCA Industry Drivers Table 26. Drugs of UDCA and t-UDCA Industry Opportunities and Challenges Table 27. Drugs of UDCA and t-UDCA Industry Restraints Table 28. Global Drugs of UDCA and t-UDCA Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Drugs of UDCA and t-UDCA Revenue Market Share by Company (2021-2026) Table 30. Global Drugs of UDCA and t-UDCA Sales by Company (2021-2026) & (K Units) Table 31. Global Drugs of UDCA and t-UDCA Sales Share by Company (2021-2026) Table 32. Global Drugs of UDCA and t-UDCA Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Drugs of UDCA and t-UDCA Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Drugs of UDCA and t-UDCA Major Company Production Sites and Headquarters Table 35. Global Drugs of UDCA and t-UDCA Company, Product Type & Application Table 36. Global Drugs of UDCA and t-UDCA Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Drugs of UDCA and t-UDCA by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Drugs of UDCA and t-UDCA Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Drugs of UDCA and t-UDCA Sales by Region (2021-2026) & (K Units) Table 41. Global Drugs of UDCA and t-UDCA Sales Market Share in Volume by Region (2021-2026) Table 42. Global Drugs of UDCA and t-UDCA Sales by Region (2021-2026) & (US$ Million) Table 43. Global Drugs of UDCA and t-UDCA Sales Market Share in Value by Region (2021-2026) Table 44. Global Drugs of UDCA and t-UDCA Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Drugs of UDCA and t-UDCA Sales by Region (2027-2032) & (K Units) Table 46. Global Drugs of UDCA and t-UDCA Sales Market Share in Volume by Region (2027-2032) Table 47. Global Drugs of UDCA and t-UDCA Sales by Region (2027-2032) & (US$ Million) Table 48. Global Drugs of UDCA and t-UDCA Sales Market Share in Value by Region (2027-2032) Table 49. Global Drugs of UDCA and t-UDCA Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Drugs of UDCA and t-UDCA Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 52. Global Drugs of UDCA and t-UDCA Sales Market Share in Volume by Application (2021-2026) Table 53. Global Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (US$ Million) Table 54. Global Drugs of UDCA and t-UDCA Sales Market Share in Value by Application (2021-2026) Table 55. Global Drugs of UDCA and t-UDCA Price by Application (2021-2026) & (US$/Unit) Table 56. Global Drugs of UDCA and t-UDCA Sales by Application (2027-2032) & (K Units) Table 57. Global Drugs of UDCA and t-UDCA Sales Market Share in Volume by Application (2027-2032) Table 58. Global Drugs of UDCA and t-UDCA Sales by Application (2027-2032) & (US$ Million) Table 59. Global Drugs of UDCA and t-UDCA Sales Market Share in Value by Application (2027-2032) Table 60. Global Drugs of UDCA and t-UDCA Price by Application (2027-2032) & (US$/Unit) Table 61. North America Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 62. North America Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 64. Europe Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 68. Latin America Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Application (2021-2026) & (US$ Million) Table 71. Bruschettini Company Information Table 72. Bruschettini Business Overview Table 73. Bruschettini Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bruschettini Drugs of UDCA and t-UDCA Product Portfolio Table 75. Bruschettini Recent Development Table 76. Daewoong Pharmaceutical Company Information Table 77. Daewoong Pharmaceutical Business Overview Table 78. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product Portfolio Table 80. Daewoong Pharmaceutical Recent Development Table 81. Dr. Falk Pharma Company Information Table 82. Dr. Falk Pharma Business Overview Table 83. Dr. Falk Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Dr. Falk Pharma Drugs of UDCA and t-UDCA Product Portfolio Table 85. Dr. Falk Pharma Recent Development Table 86. Epic Pharma Company Information Table 87. Epic Pharma Business Overview Table 88. Epic Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Epic Pharma Drugs of UDCA and t-UDCA Product Portfolio Table 90. Epic Pharma Recent Development Table 91. Grindeks Company Information Table 92. Grindeks Business Overview Table 93. Grindeks Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Grindeks Drugs of UDCA and t-UDCA Product Portfolio Table 95. Grindeks Recent Development Table 96. Impax Company Information Table 97. Impax Business Overview Table 98. Impax Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Impax Drugs of UDCA and t-UDCA Product Portfolio Table 100. Impax Recent Development Table 101. Lannett Company Information Table 102. Lannett Business Overview Table 103. Lannett Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Lannett Drugs of UDCA and t-UDCA Product Portfolio Table 105. Lannett Recent Development Table 106. Mitsubishi Tanabe Pharma Company Information Table 107. Mitsubishi Tanabe Pharma Business Overview Table 108. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product Portfolio Table 110. Mitsubishi Tanabe Pharma Recent Development Table 111. Viatris Company Information Table 112. Viatris Business Overview Table 113. Viatris Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Viatris Drugs of UDCA and t-UDCA Product Portfolio Table 115. Viatris Recent Development Table 116. Shanghai Pharma Company Information Table 117. Shanghai Pharma Business Overview Table 118. Shanghai Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Shanghai Pharma Drugs of UDCA and t-UDCA Product Portfolio Table 120. Shanghai Pharma Recent Development Table 121. Teva Company Information Table 122. Teva Business Overview Table 123. Teva Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Teva Drugs of UDCA and t-UDCA Product Portfolio Table 125. Teva Recent Development Table 126. North America Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 128. North America Drugs of UDCA and t-UDCA Sales Market Share by Country (2021-2026) Table 129. North America Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Drugs of UDCA and t-UDCA Sales Market Share Forecast by Country (2027-2032) Table 131. North America Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Drugs of UDCA and t-UDCA Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Drugs of UDCA and t-UDCA Market Share by Country (2021-2026) Table 134. North America Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Drugs of UDCA and t-UDCA Market Share Forecast by Country (2027-2032) Table 136. Europe Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 138. Europe Drugs of UDCA and t-UDCA Sales Market Share by Country (2021-2026) Table 139. Europe Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Drugs of UDCA and t-UDCA Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Drugs of UDCA and t-UDCA Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Drugs of UDCA and t-UDCA Market Share by Country (2021-2026) Table 144. Europe Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Drugs of UDCA and t-UDCA Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Drugs of UDCA and t-UDCA Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Drugs of UDCA and t-UDCA Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Drugs of UDCA and t-UDCA Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Drugs of UDCA and t-UDCA Market Share by Country (2021-2026) Table 154. Asia-Pacific Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Drugs of UDCA and t-UDCA Market Share Forecast by Country (2027-2032) Table 156. Latin America Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 158. Latin America Drugs of UDCA and t-UDCA Sales Market Share by Country (2021-2026) Table 159. Latin America Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Drugs of UDCA and t-UDCA Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Drugs of UDCA and t-UDCA Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Drugs of UDCA and t-UDCA Market Share by Country (2021-2026) Table 164. Latin America Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Drugs of UDCA and t-UDCA Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Drugs of UDCA and t-UDCA Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Drugs of UDCA and t-UDCA Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Drugs of UDCA and t-UDCA Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Drugs of UDCA and t-UDCA Market Share by Country (2021-2026) Table 174. Middle East and Africa Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Drugs of UDCA and t-UDCA Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Drugs of UDCA and t-UDCA Distributors List Table 179. Drugs of UDCA and t-UDCA Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Drugs of UDCA and t-UDCA Image Figure 2. Global Drugs of UDCA and t-UDCA Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs of UDCA and t-UDCA Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs of UDCA and t-UDCA Sales (2021-2032) & (K Units) Figure 5. t-UDCA Image Figure 6. Global t-UDCA Sales YoY Growth (2021-2032) & (K Units) Figure 7. UDCA Image Figure 8. Global UDCA Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Drugs of UDCA and t-UDCA Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Drugs of UDCA and t-UDCA Market Share by Type 2025 VS 2032 Figure 11. North America Drugs of UDCA and t-UDCA Sales Market Share in Volume by Type in 2025 Figure 12. North America Drugs of UDCA and t-UDCA Sales Market Share in Value by Type in 2025 Figure 13. Europe Drugs of UDCA and t-UDCA Sales Market Share in Volume by Type in 2025 Figure 14. Europe Drugs of UDCA and t-UDCA Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Drugs of UDCA and t-UDCA Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Drugs of UDCA and t-UDCA Sales Market Share in Value by Type in 2025 Figure 17. Latin America Drugs of UDCA and t-UDCA Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Drugs of UDCA and t-UDCA Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Drugs of UDCA and t-UDCA Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Drugs of UDCA and t-UDCA Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Drugs of UDCA and t-UDCA Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hepatopathy Image Figure 24. Global Hepatopathy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Gallstone Image Figure 26. Global Gallstone Sales YoY Growth (2021-2032) & (K Units) Figure 27. Biliary Disease Image Figure 28. Global Biliary Disease Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Drugs of UDCA and t-UDCA Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Drugs of UDCA and t-UDCA Market Share by Application 2025 VS 2032 Figure 33. North America Drugs of UDCA and t-UDCA Sales Market Share in Volume by Application in 2025 Figure 34. North America Drugs of UDCA and t-UDCA Sales Market Share in Value by Application in 2025 Figure 35. Europe Drugs of UDCA and t-UDCA Sales Market Share in Volume by Application in 2025 Figure 36. Europe Drugs of UDCA and t-UDCA Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Drugs of UDCA and t-UDCA Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Drugs of UDCA and t-UDCA Sales Market Share in Value by Application in 2025 Figure 39. Latin America Drugs of UDCA and t-UDCA Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Drugs of UDCA and t-UDCA Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Drugs of UDCA and t-UDCA Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Drugs of UDCA and t-UDCA Sales Market Share in Value by Application in 2025 Figure 43. North America Drugs of UDCA and t-UDCA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Drugs of UDCA and t-UDCA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Drugs of UDCA and t-UDCA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Drugs of UDCA and t-UDCA Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Drugs of UDCA and t-UDCA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Drugs of UDCA and t-UDCA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Drugs of UDCA and t-UDCA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Drugs of UDCA and t-UDCA Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Drugs of UDCA and t-UDCA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Drugs of UDCA and t-UDCA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Drugs of UDCA and t-UDCA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Drugs of UDCA and t-UDCA Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Drugs of UDCA and t-UDCA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Drugs of UDCA and t-UDCA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Drugs of UDCA and t-UDCA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Drugs of UDCA and t-UDCA Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Drugs of UDCA and t-UDCA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Drugs of UDCA and t-UDCA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Drugs of UDCA and t-UDCA Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Drugs of UDCA and t-UDCA Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Drugs of UDCA and t-UDCA Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • t-UDCA
  • UDCA
Applications
  • Hepatopathy
  • Gallstone
  • Biliary Disease
  • Other
Companies covered
  • Bruschettini
  • Daewoong Pharmaceutical
  • Dr. Falk Pharma
  • Epic Pharma
  • Grindeks
  • Impax
  • Lannett
  • Mitsubishi Tanabe Pharma
  • Viatris
  • Shanghai Pharma
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drugs of UDCA and t-UDCA Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Drugs of UDCA and t-UDCA Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Drugs of UDCA and t-UDCA Market by Type
  6. 1.3.1 t-UDCA
  7. 1.3.2 UDCA
  8. 1.4 Global Drugs of UDCA and t-UDCA Market Size by Type
  9. 1.4.1 Global Drugs of UDCA and t-UDCA Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Drugs of UDCA and t-UDCA Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Drugs of UDCA and t-UDCA Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Drugs of UDCA and t-UDCA Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Drugs of UDCA and t-UDCA Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Drugs of UDCA and t-UDCA Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Drugs of UDCA and t-UDCA Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Drugs of UDCA and t-UDCA Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Drugs of UDCA and t-UDCA Industry Trends
  2. 2.2 Drugs of UDCA and t-UDCA Industry Drivers
  3. 2.3 Drugs of UDCA and t-UDCA Industry Opportunities and Challenges
  4. 2.4 Drugs of UDCA and t-UDCA Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Drugs of UDCA and t-UDCA Revenue (2021-2026)
  2. 3.2 Global Top Players by Drugs of UDCA and t-UDCA Sales (2021-2026)
  3. 3.3 Global Top Players by Drugs of UDCA and t-UDCA Price (2021-2026)
  4. 3.4 Global Drugs of UDCA and t-UDCA Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs of UDCA and t-UDCA Major Company Production Sites & Headquarters
  6. 3.6 Global Drugs of UDCA and t-UDCA Company, Product Type & Application
  7. 3.7 Global Drugs of UDCA and t-UDCA Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs of UDCA and t-UDCA Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs of UDCA and t-UDCA Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs of UDCA and t-UDCA Tier 1, Tier 2, and Tier 3
4 Drugs of UDCA and t-UDCA Regional Status and Outlook
  1. 4.1 Global Drugs of UDCA and t-UDCA Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Drugs of UDCA and t-UDCA Historic Market Size by Region
  3. 4.2.1 Global Drugs of UDCA and t-UDCA Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Drugs of UDCA and t-UDCA Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Drugs of UDCA and t-UDCA Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Drugs of UDCA and t-UDCA Forecasted Market Size by Region
  7. 4.3.1 Global Drugs of UDCA and t-UDCA Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Drugs of UDCA and t-UDCA Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Drugs of UDCA and t-UDCA Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drugs of UDCA and t-UDCA by Application
  1. 5.1 Drugs of UDCA and t-UDCA Market by Application
  2. 5.1.1 Hepatopathy
  3. 5.1.2 Gallstone
  4. 5.1.3 Biliary Disease
  5. 5.1.4 Other
  6. 5.2 Global Drugs of UDCA and t-UDCA Market Size by Application
  7. 5.2.1 Global Drugs of UDCA and t-UDCA Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Drugs of UDCA and t-UDCA Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Drugs of UDCA and t-UDCA Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Drugs of UDCA and t-UDCA Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Drugs of UDCA and t-UDCA Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Drugs of UDCA and t-UDCA Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Drugs of UDCA and t-UDCA Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Drugs of UDCA and t-UDCA Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bruschettini
  2. 6.1.1 Bruschettini Company Information
  3. 6.1.2 Bruschettini Business Overview
  4. 6.1.3 Bruschettini Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bruschettini Drugs of UDCA and t-UDCA Product Portfolio
  6. 6.1.5 Bruschettini Recent Developments
  7. 6.2 Daewoong Pharmaceutical
  8. 6.2.1 Daewoong Pharmaceutical Company Information
  9. 6.2.2 Daewoong Pharmaceutical Business Overview
  10. 6.2.3 Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product Portfolio
  12. 6.2.5 Daewoong Pharmaceutical Recent Developments
  13. 6.3 Dr. Falk Pharma
  14. 6.3.1 Dr. Falk Pharma Company Information
  15. 6.3.2 Dr. Falk Pharma Business Overview
  16. 6.3.3 Dr. Falk Pharma Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dr. Falk Pharma Drugs of UDCA and t-UDCA Product Portfolio
  18. 6.3.5 Dr. Falk Pharma Recent Developments
  19. 6.4 Epic Pharma
  20. 6.4.1 Epic Pharma Company Information
  21. 6.4.2 Epic Pharma Business Overview
  22. 6.4.3 Epic Pharma Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Epic Pharma Drugs of UDCA and t-UDCA Product Portfolio
  24. 6.4.5 Epic Pharma Recent Developments
  25. 6.5 Grindeks
  26. 6.5.1 Grindeks Company Information
  27. 6.5.2 Grindeks Business Overview
  28. 6.5.3 Grindeks Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Grindeks Drugs of UDCA and t-UDCA Product Portfolio
  30. 6.5.5 Grindeks Recent Developments
  31. 6.6 Impax
  32. 6.6.1 Impax Company Information
  33. 6.6.2 Impax Business Overview
  34. 6.6.3 Impax Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Impax Drugs of UDCA and t-UDCA Product Portfolio
  36. 6.6.5 Impax Recent Developments
  37. 6.7 Lannett
  38. 6.7.1 Lannett Company Information
  39. 6.7.2 Lannett Business Overview
  40. 6.7.3 Lannett Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lannett Drugs of UDCA and t-UDCA Product Portfolio
  42. 6.7.5 Lannett Recent Developments
  43. 6.8 Mitsubishi Tanabe Pharma
  44. 6.8.1 Mitsubishi Tanabe Pharma Company Information
  45. 6.8.2 Mitsubishi Tanabe Pharma Business Overview
  46. 6.8.3 Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product Portfolio
  48. 6.8.5 Mitsubishi Tanabe Pharma Recent Developments
  49. 6.9 Viatris
  50. 6.9.1 Viatris Company Information
  51. 6.9.2 Viatris Business Overview
  52. 6.9.3 Viatris Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Viatris Drugs of UDCA and t-UDCA Product Portfolio
  54. 6.9.5 Viatris Recent Developments
  55. 6.10 Shanghai Pharma
  56. 6.10.1 Shanghai Pharma Company Information
  57. 6.10.2 Shanghai Pharma Business Overview
  58. 6.10.3 Shanghai Pharma Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shanghai Pharma Drugs of UDCA and t-UDCA Product Portfolio
  60. 6.10.5 Shanghai Pharma Recent Developments
  61. 6.11 Teva
  62. 6.11.1 Teva Company Information
  63. 6.11.2 Teva Business Overview
  64. 6.11.3 Teva Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Teva Drugs of UDCA and t-UDCA Product Portfolio
  66. 6.11.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Drugs of UDCA and t-UDCA Sales by Country
  2. 7.1.1 North America Drugs of UDCA and t-UDCA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Drugs of UDCA and t-UDCA Sales by Country (2021-2026)
  4. 7.1.3 North America Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032)
  5. 7.2 North America Drugs of UDCA and t-UDCA Market Size by Country
  6. 7.2.1 North America Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Drugs of UDCA and t-UDCA Market Size by Country (2021-2026)
  8. 7.2.3 North America Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Drugs of UDCA and t-UDCA Sales by Country
  2. 8.1.1 Europe Drugs of UDCA and t-UDCA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Drugs of UDCA and t-UDCA Sales by Country (2021-2026)
  4. 8.1.3 Europe Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Drugs of UDCA and t-UDCA Market Size by Country
  6. 8.2.1 Europe Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Drugs of UDCA and t-UDCA Market Size by Country (2021-2026)
  8. 8.2.3 Europe Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Drugs of UDCA and t-UDCA Sales by Country
  2. 9.1.1 Asia-Pacific Drugs of UDCA and t-UDCA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Drugs of UDCA and t-UDCA Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Drugs of UDCA and t-UDCA Market Size by Country
  6. 9.2.1 Asia-Pacific Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Drugs of UDCA and t-UDCA Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Drugs of UDCA and t-UDCA Sales by Country
  2. 10.1.1 South America Drugs of UDCA and t-UDCA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Drugs of UDCA and t-UDCA Sales by Country (2021-2026)
  4. 10.1.3 South America Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032)
  5. 10.2 South America Drugs of UDCA and t-UDCA Market Size by Country
  6. 10.2.1 South America Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Drugs of UDCA and t-UDCA Market Size by Country (2021-2026)
  8. 10.2.3 South America Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Drugs of UDCA and t-UDCA Sales by Country
  2. 11.1.1 Middle East and Africa Drugs of UDCA and t-UDCA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Drugs of UDCA and t-UDCA Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Drugs of UDCA and t-UDCA Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Drugs of UDCA and t-UDCA Market Size by Country
  6. 11.2.1 Middle East and Africa Drugs of UDCA and t-UDCA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Drugs of UDCA and t-UDCA Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Drugs of UDCA and t-UDCA Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Drugs of UDCA and t-UDCA Value Chain Analysis
  2. 12.1.1 Drugs of UDCA and t-UDCA Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Drugs of UDCA and t-UDCA Production Mode & Process
  7. 12.2 Drugs of UDCA and t-UDCA Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Drugs of UDCA and t-UDCA Distributors
  10. 12.2.3 Drugs of UDCA and t-UDCA Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst